New Data for MS drug Tysabri released at AAN annual meeting

[MSUK]

- New Tysabri® analysis shows improved walking speed in significant number of MS patients.

- Additional data show escalation to Tysabri following relapse improves clinical outcomes compared to remaining on or switching between first-line Interferon Beta and Glatiramer Acetate.............. Read More - http://www.ms-uk.org/tysabri

[HarryZ]

- New Tysabri® analysis shows improved walking speed in significant number of MS patients.

- Additional data show escalation to Tysabri following relapse improves clinical outcomes compared to remaining on or switching between first-line Interferon Beta and Glatiramer Acetate.............. Read More - http://www.ms-uk.org/tysabri

Data presented by Biogen!! Remember this was the company that told us Tysabri was safe when it was first released and then held off announcing to the world the news about PML while its execs made millions by selling their stock. Have to admit though that it's a good marketing ploy to boost sales.